Lixte Biotechnology
LIXT
LIXT
6 hedge funds and large institutions have $92.8K invested in Lixte Biotechnology in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
70% less capital invested
Capital invested by funds: $307K → $92.8K (-$214K)
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12K | |
| 2 | +$2.58K | |
| 3 | +$7 | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2 |